Skip to content

DMT clinical trials: pipeline by phase and status

Every trial in this library's ClinicalTrials.gov slice that names DMT: 70 registered studies, grouped by phase and by recruitment status. For the published research, see the DMT research page.

The pipeline at a glance

By phase
PhaseTrials
Early phase 1 2
Phase 1 23
Phase 1/2 4
Phase 2 6
Phase 3 7
Phase 4 4
Not applicable 12
Unspecified 12
By status
StatusTrials
Recruiting or planned 12
Active, not recruiting 7
Completed 43
Stopped 4
Unknown or other 4

17,150 participants across the 70 trials that report enrollment. The earliest registered start is 2006, and 17 trials started in the last two years.

Most active sponsors

  • University Hospital, Basel, Switzerland 7 trials
  • GH Research Ireland Limited 6 trials
  • Novartis Pharmaceuticals 6 trials
  • Biomind Labs Inc. 3 trials
  • Universidade Federal do Rio Grande do Norte 3 trials

Evidence by condition

All 70 trials

Most advanced phase first, and within each phase the most recent start date first.

Phase 4 4 trials

Phase 3 7 trials

Phase 2 6 trials

Phase 1/2 4 trials

Phase 1 23 trials

Early phase 1 2 trials

Not applicable 12 trials

Unspecified 12 trials

Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.